The Amyloidosis Center at Boston University School of Medicine and Boston Medical Center is recognized internationally as a leader in basic and clinical research on amyloidosis and related diseases. Vaishali Sanchorawala, MD, is the Director and has been affiliated with the Center since 1994. The Center is unique in its approach, providing exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research. The mission of this center is to serve as a:

• Referral center for evaluation and treatment of patients with amyloid diseases.

• Coordinating center for clinical trials and laboratory research on systemic amyloidosis.

• Reference laboratory for amyloid pathology and molecular diagnostics.

• Resource for information on amyloidosis for patients and their families, physicians, and scientists.

The Amyloidosis Center coordinates the multidisciplinary evaluation of patients with amyloidosis by sub-specialists who are experts in amyloid diseases. The clinical program works closely with the stem cell transplant program in the Section of Hematology-Oncology, Department of Medicine, directed by Vaishali Sanchorawala, MD, and with the clinical trials office.

The team includes healthcare professionals in the following areas:

Cardiology:
Frederick L. Ruberg, MD

Nephrology:
Lauren D Stern, MD; Andrea I. Havasi, MD

Hematology and Oncology:
John M. Sloan, MD; Vaishali Sanchorawala, MD

Neurology:
Kwan Hon Vincent Lau, MD